AMGN

President Trump Loaded Up on Eli Lilly in Q1. Should You Buy the Obesity Drug Stock Too?

05/27 02:02 pm

AI Bots Crashed $10K in 2 Weeks While This ’Beat-the-Bot’ Divvie Sails Higher

05/27 05:22 am

My Personal Plan to Turn Market Chaos Into 300%+ Growth

05/26 05:13 am

CytomX Therapeutics to Present at Upcoming June Investor Conferences

05/21 08:00 am

Eli Lilly Stock: Next Stop $2,000?

05/18 06:30 pm

Amgen Japanese Partner Urges Caution On Tavneos Use

05/18 11:18 am

Oligonucleotides Clinical Trial Drug Development Pipeline Expands with Contributions from 200+ Key Companies | DelveInsight

05/14 01:00 pm

Global Colorectal Cancer Diagnostics and Therapeutics Market Anticipates Impressive Growth Trajectory at a CAGR of ~9% by 2034 | DelveInsight

05/13 01:00 pm

Wall Street's Cardiac Bet: Where Diagnostics Meet the Money

05/12 08:30 am

Global Personalized Medicine to Transform Modern Healthcare and Cross USD 1 Trillion by 2034 | DelveInsight

05/11 01:00 pm

2 Dividend Stocks to Double Up On Right Now

05/08 01:30 pm

Accumulus Technologies gibt die Live-Integration mit Veeva RIM bekannt und ermöglicht damit eine nahtlose Verbindung zwischen RIM und den Aufsichtsbehörden

05/07 01:48 pm

Accumulus Technologies annonce la mise en service de son intégration avec Veeva RIM, permettant une connexion fluide entre les systèmes RIM et les autorités réglementaires

05/07 01:48 pm

Stock Market Today: Apple Earnings Power S&P 500, Nasdaq To Records; Trump Hits EU

05/01 01:11 pm

FDA Announces Major Steps to Implement Real-Time Clinical Trials

04/28 01:49 pm

Mag 7 Earnings Bonanza, Fed Await Stocks at Record Highs: What to Expect

04/27 05:36 am

Chronic Obstructive Pulmonary Disease Clinical Trial Landscape Expands: Over 65 Companies Advancing Next-Generation Therapies | DelveInsight

04/23 01:00 pm

Kopp Family Office Trims $3.5 Million Worth of Viridian Therapeutics Stake -- What Investors Should Know

04/21 03:26 pm

Bispecific Antibody Drug Conjugates Market Landscape Report 2026: A $2 Billion Opportunity by 2030 with the 1st Approved BsADC by 2028 - Clinical Trials, Regulatory Approvals, Development Platforms

04/21 04:49 am

Bispecific Antibody Market Landscape Report 2026: A Potential $60 Opportunity by 2031 - Insight on More than 550 Clinical Trials - Antibody Dosage, Patent, Price, Sales & Outlook

04/21 04:34 am

Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer

04/20 07:00 am

Eosinophilic Esophagitis Market in the US to Grow at 13.2% CAGR During the Forecast Period (2026–2036) Owing to the Emergence of Drug Classes Such as TSLP Inhibitors, Glucocorticoid Receptor Agonists, and Immunomodulators | DelveInsight

04/13 01:00 pm

Atopic Dermatitis 68-Market Drug Forecast and Market Analysis Report 2023-2025 & 2025-2033

04/10 04:46 am

Martin Capital Dumps $4.5 Million in Robert Half Shares After a Brutal Year for the Staffing Sector

04/07 03:18 pm

Trump Imposes 100% Drug Tariffs: 5 Pharma Stocks That Won’t Pay a Dime

04/06 01:20 pm

2 Healthcare Dividend Stocks to Buy as the Tech-Heavy Nasdaq Dips Below Correction Territory

04/02 05:32 pm

Dow, S&P 500, Nasdaq: From Morning Meltdown to Midday "Meh"

04/02 02:25 pm

Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report

04/02 04:44 am

Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx

04/01 08:01 am

FDA Warns Of Fatal Liver Risks Linked To Amgen Tavneos Use

03/31 02:05 pm

Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)

03/30 08:00 am

Teva gewinnt an Dynamik im Biosimilar-Geschäft mit der FDA-Zulassung für PONLIMSI™ (Denosumab-adet) und der Annahme von parallelen Zulassungsanträgen für einen Biosimilar-Kandidaten zu Xolair® (Omalizumab)

03/30 08:00 am

Teva gagne du terrain dans le domaine des médicaments biosimilaires grâce à l’approbation accordée par la FDA pour PONLIMSI™ (dénosumab-adet) et à l’acceptation d’un double dossier pour un candidat biosimilaire à Xolair® (omalizumab)

03/30 08:00 am

This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks

03/30 06:30 am

SK pharmteco to Host Innovations in Pharmaceutical Manufacturing Symposium in Cambridge, Massachusetts

03/26 10:00 am

2 Healthcare Stocks to Buy Before They Get Bought Out

03/20 05:34 am

CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants

03/17 10:46 pm

Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report

03/16 07:19 am

1 ETF That Could Turn $100 Per Month Into $67,380

03/15 05:05 am

Better Weight Loss Stock: Novo Nordisk Vs. Amgen

03/08 02:30 pm

Cytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market

03/05 05:44 am

AMGEN ANNOUNCES 2026 SECOND QUARTER DIVIDEND

03/04 05:01 pm

GLP-1 Receptor Agonist Business Analysis Report 2026: Market to Reach $137.4 Billion by 2030 - Clinical Trials Exploring GLP-1 Role in NAFLD and NASH Unlock Future Opportunities

03/04 06:48 am

A Couple's Financial Manifesto, Revisited

03/02 12:19 pm

A Symbol of Crisis: As Colorectal Cancer Deaths Rise, Fight CRC Installs United in Blue on the National Mall

02/27 03:52 pm

One in Three Rheumatologists View BMS’ Sotyktu as a Substantial Advance in Psoriatic Arthritis Ahead of March 6 FDA Decision, According to Spherix Global Insights Data

02/27 01:31 pm

Your Kidneys Count: American Kidney Fund Urges Americans to Protect Their Health this Kidney Month

02/27 10:52 am

VivaVision Eyes Hong Kong Listing Before Cash Coffers Dry Up

02/26 02:46 pm

Advanced Drug Delivery Market to Grow 10.2% Annually Through 2030

02/25 01:54 pm

CVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder

02/06 02:52 pm